CUL4A and CUL4B are closely related cullin family members and can each assemble a Cullin-RING E3 ligase complex (CRL) and participate in a variety of biological processes. While the CRLs formed by the two cullin members may have common targets, the two appeared to have very different consequences when mutated or disrupted in mammals. We here investigated the roles of cul4a and cul4b during zebrafish embryogenesis by using the morpholino knockdown approach. We found that cul4a is essential for cardiac development as well as for pectoral fin development. Whereas cul4a morphants appeared to be unperturbed in chamber specification, they failed to undergo heart looping. The failures in heart looping and pectoral fin formation in cul4a morphants were accompanied by greatly reduced proliferation of cardiac cells and pectoral fin-forming cells. We demonstrated that tbx5a, a transcription factor essential for heart and limb development, is transcriptionally upregulated by cul4a and mediates the function of cul4a in cardiac and pectoral fin development. In contrast to the critical importance of cul4a, cul4b appeared to be dispensable for zebrafish development and was incapable of compensating for the loss of cul4a. This work provides the first demonstration of an essential role of cul4a, but not cul4b, in cardiac development and in the regulation of tbx5a in zebrafish. These findings justify exploring the functional role of CUL4A in human cardiac development.
INTRODUCTION
Cullin-RING E3 ligase (CRLs) complexes, which contain cullin, RING protein and substrate-recognition subunit as the core components, represent the largest known class of ubiquitin ligases and participate in a broad variety of physiologically and developmentally controlled processes such as cell cycle progression, transcription and signal transduction (1 -3) . Among cullin family members, CUL4A and CUL4B have the highest degree of homology, with 80% identity in protein sequences, and are believed to be derived from one common ancestor Cul4 (4) . There is only one ortholog, Cul4, in lower organisms. Acting as the scaffold component, CUL4 assembles with ROC1 at its C terminus and with damaged DNA-binding protein 1 (DDB1) at its N terminus to form CRL4 complex (1 -4).
As CUL4A and CUL4B share a high degree of homology and utilize the same adapter protein DDB1 in assembling CRL4 complexes, they can potentially target the same substrates and function redundantly in some cellular functions (5) . However, when mutated or disrupted, those two genes appeared to have very different consequences. Mutations in human CUL4B have been found to be a common cause of X-linked mental retardation (XLMR) (6, 7) . To date, at least 12 families of XLMR have been reported to be attributable to the loss-of-function mutations in CUL4B (6 -10) . In addition to being mentally retarded, patients carrying CUL4B mutation also manifest short stature, abnormal gait, impaired speech and other abnormalities (6 -9,11) . These phenotypes underscore the functional importance of CUL4B. Furthermore, in peripheral blood of human CUL4B heterozygotes, cells in which the mutant CUL4B resides on the active X chromosome were strongly selected against (6, 10) . Accordingly, Cul4b null mice are embryonic lethal and Cul4b nonfunctional cells are selected against in Cul4b heterozygous mice (12) . Recent reports showed that Cul4b is particularly critical for the development of extraembryonic tissues (12, 13) . CUL4B has also been shown to promote tumorigenesis and to be highly expressed in a broad variety of cancer (14, 15) . Recently, we showed that CRL4B can also catalyze H2AK119 monoubiquitation and, by coordinating with PRC2, promote H3K27 trimethylation, leading to the transcriptional repression of tumor suppresser genes and enhanced tumorigenesis (14) .
On the other hand, no germline mutations in the human CUL4A gene have been documented, although CUL4A is found to be overexpressed in breast cancers, hepatocellular carcinomas, squamous cell carcinomas, adrenocortical carcinomas and childhood medulloblastoma (16) (17) (18) (19) (20) (21) . In addition, Cul4a knockout mice were viable and displayed no apparent developmental phenotype except that the knockout males were sterile due to impaired spermatogenesis (22) (23) (24) . These results suggest that the two CUL4 genes are not entirely redundant in mammals.
Zebrafish have been extensively used as a model for the study of embryogenesis. A recent study showed that cereblon (CRBN)-mediated CRL4A E3 ligase activity is critical for several important developmental processes such as limb outgrowth and otic vescles in zebrafish (25) . Knockdown of crbn or cul4a caused specific defects in pectoral fin and otic vesicle development. Interestingly, as the substrate receptor for CRL4A, CRBN is also targeted by thalidomide, a well-known teratogen. Therefore, new functions of CUL4A and CUL4B remain to be identified.
In this study, we examined the roles of cul4a and cul4b during zebrafish embryogenesis and found that cul4a, but not cul4b, plays an essential role during heart and limb development. We demonstrated that cul4a is required for the expression of tbx5a, an essential transcription factor in heart and limb development. This study provides the first demonstration of a crucial role for cul4a in cardiovascular development.
RESULTS
Knockdown of cul4a, but not cul4b, results in developmental defects in zebrafish As in mammals, there are two cul4 members, cul4a and cul4b, in zebrafish. The two have a high degree of homology with their respective mammalian counterparts CUL4A and CUL4B (Fig. 1A) . Zebrafish cul4a, which resides on chromosome 1 and encodes 635 amino acids, displays 80% amino acid identity to human CUL4A, and cul4b, on chromosome 14 and encoding 864 amino acids, has 84% amino acid identity to human CUL4B. As expected, the protein sequences of zebrafish cul4a and cul4b also show a high degree of homology (78%) (Fig. 1A) .
To determine the physiological roles of cul4a and cul4b in vivo, we designed cul4a-and cul4b-specific MOs, designated as cul4a-MO1 and cul4b-MO1, respectively, to block the splice donor junction of exon 2 (Fig. 1B) . The MOs were predicted to skip exon 2 in the final mRNA transcripts, thereby changing the reading frame and introducing a stop codon. Splice-blocking MOs are advantageous as the knockdown efficiency can be evaluated using RT-PCR. To validate the efficacy of cul4a-MO1 and cul4b-MO1, primers flanking exon 2 were employed for RT-PCR amplification of cul4a or cul4b in wildtype and MO-injected embryos at 24 h post fertilization (hpf). As shown in Figure 1C , injection of 4 ng of cul4a-MO1 or cul4b-MO1 resulted in complete exclusion of exon 2 from the cul4a or cul4b mRNA, which was confirmed by cDNA sequencing (Fig. 1D) . The deletion in cul4a would result in a frameshift consisting of eight missense codons followed by a stop codon. The mutant allele is thus predicted to generate a peptide of merely 44 amino acids, if it were to be expressed. There was no detectable inhibition of cul4a splicing in embryos injected with control morpholino (cul4a-CMO), which has five mismatches with cul4a-MO1. Similarly, injection of 4 ng cul4b-MO1 resulted in the complete exclusion of exon 2 from the cul4b mRNA, as shown by the absence of the 571 bp product representing wild-type cul4b message and the presence of a smaller 455 bp product (Fig. 1C, bottom) . These data indicate that these MOs were efficient in disrupting the expression of their target genes in zebrafish embryos.
We determined the dose of the MOs required for knocking down the target genes by injecting 1 -4 ng of CMO, cul4a-MO1 or cul4b-MO1 into one-cell stage zebrafish embryos and allowed them to develop for 3 days post fertilization (dpf). Unexpectedly, the cul4b-MO1-injected embryos (cul4b morphants) were phenotypically indistinguishable from cul4b-CMO-injected embryos ( Fig. 2A) . To confirm this observation, a separate morpholino, cul4b-MO2, was designed to target the 5 ′ -UTR of cul4b to inhibit translation. Experiments with cul4b-MO2 produced similar results ( Fig. 2A) , suggesting that lack of cul4b is compatible with normal zebrafish development.
In contrast to the lack of abnormal phenotypes in cul4b morphants, cul4a-MO1-injected embryos (cul4a morphants) displayed an array of profound morphological defects, including tail curling, hindbrain edema, stunted or completely absent pectoral fins and pericardial edema that was accompanied by heart looping defects ( Fig. 2B-E) . To exclude possible off-target effects of cul4a-MO1, a second morpholino, cul4a-MO2, was designed to inhibit cul4a translation by targeting its 5 ′ -UTR. Embryos injected with cul4a-MO2 exhibited similar phenotypes ( Fig. 2B-E; Supplementary Material, Fig. S1 ), confirming an important role of cul4a in zebrafish development.
We next performed rescue experiment in cul4a morphants by injecting a mixture of capped zebrafish cul4a mRNA and cul4a-MO1 into one-cell embryos. While only 15.2% (16 of 105) embryos appeared normal when cul4a-MO1 alone was injected, co-injection of cul4a mRNA and cul4a-MO1 increased the percentage of normal embryos to 79.3% (130/164) at 72 hpf, which was comparable with that in the cul4a-CMO-injected group, indicating that the abnormalities caused by cul4a-MO1 can be rescued by co-injection of zebrafish cul4a mRNA (Fig. 2F) . Interestingly, the defects of cul4a morphants could also be rescued by co-injection of human CUL4A mRNA, indicating a functional conservation of this protein between zebrafish and humans (Fig. 2F) . Strikingly, we also observed that human CUL4B mRNA was as effective as CUL4A mRNA in rescuing the developmental defects in cul4a morphants (Fig. 2F) . Zebrafish cul4b mRNA, on the other hand, was ineffective. Furthermore, we also examined the gross morphology of cul4a and cul4b double knockdown zebrafish (Fig. 2G ) and found that 19.1% (33/173) of the cul4a/cul4b double knockdown embryos appeared normal, which was comparable with cul4a single knockdown embryos. These results indicate that cul4b is dispensable for zebrafish development and is incapable of compensating for the loss of cul4a.
Knockdown of cul4a led to heart looping failure To further define the cardiac abnormality in cul4a morphants, we injected cul4a-CMO or cul4a-MO1 into zebrafish embryos of the transgenic line Tg(cmlc:gfp) in which enhanced green fluorescent protein is expressed in all cardiac cells (26) . Although the initial heart tubes in cul4a morphants were indistinguishable from those in controls at 24-33 hpf (Fig. 3A and B) , abnormalities were noted at later developmental stage. At 48 hpf, the heart tubes in cul4a-MO1 morphants remained relatively straight, whereas they appeared to loop to the right in CMO-injected embryos ( Fig. 3C and D) . At 60 hpf, the hearts in cul4a-MO1 RT-PCR was performed to test the efficiency of the cul4a (top) and cul4b (bottom) splice-blocking MOs. There was no inhibition of splicing in embryos injected with a mismatch control MO, while 4 ng of cul4a MO1 or 4 ng of cul4b MO1 efficiently blocks mRNA splicing. Bands of 415 and 299 bp represent wild-type and exon 2-deleted cul4a mRNA, respectively (top), and bands of 571 and 455 bp represent wild-type and exon 2-deleted cul4b mRNA, respectively (bottom). (D) cDNA sequencing of cul4a (top) and cul4b (bottom) from the embryos injected with the cul4a-MO1 or cul4b-MO1. As predicted, exon 1 was spliced onto exon 3 after blocking the exon 2 splicing. The stop codon is underlined. morphants remained configured as cylinders, though there was no obvious perturbation in cmlc-driven GFP expression when compared with the controls (Fig. 3E and F). Cul4a morphants also showed significantly slower heart rhythm than the controls ( Fig. 3G) . At 60 hpf, MO1 and CMO morphants differed by 26 beats/min, 123 + 10 beats/min (n ¼ 30) versus 149 + 5 beats/min (n ¼ 29), P , 0.001. At 72 hpf, the difference increased to 42 beats/min, 170 + 20 beats/min (n ¼ 38) versus 212 + 13 beats/min (n ¼ 25), P , 0.001. Together, these data indicate that the cardiac development in cul4a morphants was structurally and functionally impaired. To determine the developmental stage when cardiac development was first perturbed in cul4a morphants, we injected embryos with cul4a-CMO or cul4a-MO1 and processed them for in situ hybridization with various cardiac markers. Examination of cardiac myosin light chain 2 (cmlc2), a pan-cardiac marker (27) , revealed no difference between the two groups during the early stage of the cardiac development, from the time when cardiac cone appears, through the period of tube formation, to the stage of cardiac jogging (Fig. 4A, top) , indicating that the myocardial specification occurred normally in cul4a morphants. By 48 hpf, however, when the hearts in cul4a-CMO-injected embryos were observed to bend rightward in the ventricular region (D-loop), this landmark of cardiac development was not noted in cul4a morphants (Fig. 4A, bottom) . Thus, the cardiac defect caused by cul4a deficiency was not evident until the cardiac looping stage.
To determine whether the chamber identity was altered in cul4a morphants, we examined cardiac chamber development by using monoclonal antibodies against pan cardiac as well as chamber-specific myosin markers (27, 28) . Immunostaining of MF20, which is expressed in all cardiomyocytes, revealed no notable difference between control and cul4a morphants at 48 hpf (Fig. 4B) . The expression pattern of atrial marker S46 also appeared to be similar between cul4a morphants and control embryos (Fig. 4C) . We also compared the distributions of ventricular myosin heavy chain (vmhc) (27) . At 48 hpf, the expression pattern of vmhc in cul4a morphants was again indistinguishable from that in control embryos, indicating that the ventricular specification proceeded normally in cul4a morphants (Fig. 4D) . Altogether, these data indicate that chamber specification and initial differentiation were unperturbed in cul4a knockdown embryos.
Increased apoptosis and decreased proliferation of myocardial cells in the cul4a morphants
Cell proliferation, cellular organization and cell shape changes have been suggested to contribute to cardiac looping (29 -31) . To investigate the mechanism underlying the failure in heart looping in cul4a morphants, we investigated whether the number of cardiomyocytes was decreased in cul4a morphants. Examination of histological sections of cul4a-MO1-injected embryos at 3 dpf showed that the walls of ventricle and atrium were markedly thinner than those in age-matched controls, and the cardiomyocytes were more scarcely distributed along the ventricular and atrial walls in cul4a morphants (Fig. 5A) .
The observed paucity of cardiac cells in cul4a morphants prompted us to characterize the levels of apoptosis and proliferation during heart looping. Apoptosis was examined using TUNEL assay (Fig. 5B) . While no obvious apoptosis was observed in the atria or ventricle of cul4a-CMO-injected embryos, a remarkable number of apoptotic cells were detected in the heart of cul4a knockdown embryos (Fig. 5B ). This result indicates that the cardiac cells in cul4a morphants were impaired in their survival.
We examined cell proliferation using a polyclonal antibody against proliferating cell nuclear antigen (PCNA). Immunostaining of PCNA indicated that the number of dividing cardiac cells was lower in cul4a morphants than in cul4a-CMO embryos (Fig. 5C ). To validate this result, we injected bromodeoxyuridine (BrdU) into the pericardiac cavity at 48 hpf and processed the embryos for BrdU staining 1 h later (30) . As shown in Figure 5D , the number of BrdU-positive cells was significantly decreased in the heart of cul4a-MO1-injected embryos, compared with that in control embryos (cul4a-CMO: 29.5 + 1.5, n ¼ 4; cul4a-MO1: 13.3 + 4.7, n ¼ 3). These results indicate that the cardiac cells in cul4a morphants were impaired in their proliferation.
In addition to having a low cell number, the cardiac cells in the cul4a morphants also appeared to be disorganized when The cmlc-driven GFP is expressed in cardiomyocytes of transgenic Tg(cmlc:gfp) embryos. Compared with the looped heart of embryos injected with cul4a-CMO (A, C and E), the heart of cul4a morphants remained in a straight tubular shape at 27, 48 and 60 hpf (B, D and F). (G) Heart rhythm at different stages of cul4a morphants and controls. Scale bar: 200 mm. #: P , 0.001. compared with the controls. Whereas the cardiomyocytes were cuboidal and well compacted in cul4a-CMO-injected Tg(cmlc2:gfp) embryos, they were irregularly shaped and were distributed in disarray in cul4a-MO1-injected embryos (Fig. 5E) . Thus, there is an insufficient supply of cardiomyocytes in cul4a morphants, which may have led to irregularity in cell shape and compaction, and consequently the failure in heart looping.
Impaired pectoral fin development in cul4a knockdown zebrafish
Injection of cul4a-MO1 also led to the truncation or absence of pectoral fins in zebrafish. The length of pectoral fins was 73.73 + 69.87 mm (n ¼ 16) in average in cul4a morphants, compared with 285.84 + 38.89 mm (n ¼ 19) in controls (Fig. 6A) . Alcian Blue staining, which marks cartilage and bone structures in the developing embryos, also revealed shortened or absent pectoral fins in cul4a morphants (Fig. 6B) . One-hour pulse of BrdU at 33 hpf revealed fewer proliferating (BrdU-positive) cells in the buds of pectoral fins in cul4a morphants than in control embryos (Fig. 6C) . These results suggest that, as for the failure of heart looping in cul4a morphants, proliferation defect might also be responsible for the failure in the pectoral fin development.
Tbx5a was downregulated in cul4a morphants
We noted that the phenotypes displayed by cul4a morphants were reminiscent of those in tbx5a mutants or tbx5a knockdown morphants (32, 33) . Both tbx5a and cul4a morphants exhibited structural defects in heart and pectoral fin. The common phenotypes shared between cul4a and tbx5a loss-of-function morphants prompted us to test whether the two lie in the same pathway. We first examined the expression of cul4a in heart and pectoral fins and found that cul4a was highly expressed in those organs (Fig. 7A ). This expression pattern was similar to that of tbx5a previously reported (32, 33) . We then determined the levels of tbx5a mRNA in control and cul4a-MO1-treated zebrafish embryos at 32 hpf by quantitative RT-PCR. The tbx5a expression was remarkably reduced in cul4a-MO1-injected embryos compared with that in embryos injected with cul4a-CMO (Fig. 7B) . The downregulation of tbx5a in cul4a morphants was confirmed at protein level (Fig. 7C) . Whole-mount in situ hybridization using tbx5a probes also indicated a reduction in tbx5a expression in the heart and in the buds of pectoral fins in cul4a morphants (Fig. 7D) , which corresponded to the lack of cul4a expressions in those regions. Because tbx5a functions as a transcription factor, we thus also measured the expression levels of its transcriptional targets fgf10 and hand2. As expected, the target genes were significantly downregulated (Fig. 7B) .
We next determined whether the phenotypes caused by cul4a knockdown were mediated by the downregulation of tbx5a by co-injecting tbx5a mRNA and cul4a-MO1 into zebrafish embryos. We found that co-injection of tbx5a mRNA significantly rescued the developmental defects in cul4a morphants, with the percentage of embryos with malformed heart and pectoral fin significantly decreased (Fig. 7E) . These results indicated that the phenotypes of cul4a morphants were mediated by the downregulation of tbx5a.
The finding that cul4a can positively regulate tbx5a expression during zebrafish development is analogous to the report that CUL4A contributes to transcriptional activation of p16 in human tumor cells by coordinating with H3K4 methyltransferase MLL1 complex (34) . Thus, we next tested whether CUL4A could activate Tbx5a expression in H9C2, a line of rat myocardial cells. As expected, knockdown of Cul4a resulted in a reduction of Tbx5a expression at both mRNA and protein levels ( Fig. 7F and G) , suggesting that Cul4a can positively regulate the expression of Tbx5a. To further support this notion, we used chromatin immunoprecipitation (ChIP) to examine whether Cul4a directly binds to the promoter of Tbx5a gene. As shown in Figure 7H , Cul4a is directly bound to the 2908 to 2511 bp region of Tbx5a promoter. Notably, H3K4me3, a histone mark associated with transcriptional activation, was also enriched in the same region (Fig. 7H) . Furthermore, knockdown of Cul4a led to a significant decrease in the enrichment of Cul4a and H3K4me3 on the Tbx5a promoter. These results suggest that Cul4a can directly bind to the promoter of Tbx5a gene and promotes H3K4 trimethylation, leading to the transcriptional activation of Tbx5a.
DISCUSSION
By assembling various CRL4 E3 ubiquitin ligase complexes, CUL4 participates in the regulation of a broad spectrum of biological processes. Studies done on CUL4A and CUL4B, the two mammalian CUL4 paralogs, showed that CUL4A and CUL4B may each form their own ubiquitin ligase complexes that target different substrates for proteosomal degradation or for protein modification (14, 35, 36) . Loss-of-function mutations in CUL4B lead to impaired cognitive development, absence of speech, short stature and other abnormalities in humans. However, while constitutive Cul4b knockout mice are embryonic lethal (12, 13) , conditional Cul4b KO mice in which Cul4b function is only retained in extraembryonic tissues exhibit relatively mild phenotypes (13, 37) . Cul4a knockout mice are even less affected (22 -24) . To determine the respective roles of cul4a and cul4b in zebrafish development, we knocked down cul4a and cul4b, respectively, in zebrafish by the morpholino and characterized the phenotypes of the cul4a and cul4b knockdown morphants. We found, to our surprise, that the phenotypes of cul4a knockdown morphants are drastically different from those of cul4b morphants. While cul4a morphants were severely impaired in their cardiac development and pectoral fin morphogenesis, cul4b morphants exhibited no obvious phenotypes, indicating that cul4a is functionally more important than cul4b in zebrafish. Interestingly, we found that the phenotypes of cul4a morphants could be rescued by human CUL4B mRNA, but not by zebrafish cul4b mRNA. Together, these findings suggest that the functions of cul4 paralogs are varied in different species.
We showed that while the chamber specification and initial differentiation were unperturbed, the cul4a morphants failed to undergo heart looping. The cardiac cells appeared to be scarcer along the ventricular and atrial walls of cul4a morphants than in the control. The scarcity of cardiac cells is probably due to their reduced rate of proliferation. The cul4a morphants were also affected in their pectoral fin development. As in the developing hearts of cul4a morphants in which the proliferation of myocardial cells was reduced, the regions that would give rise to the buds of pectoral fins in cul4a morphants contained much fewer proliferating cells. Thus, both the cardiac and the forelimb defects are likely to be caused by an insufficient supply of cells that would constitute the organs.
Transcription factor Tbx5a has been well documented to play a critical role in cardiac development and limb morphogenesis (33) . Mutations in TBX5a cause Holt-Oram syndrome that is characterized by morphological defects in heart and forelimb, and progressive cardiac conduction disease (38) . Tbx5a deficiency in mammalian and zebrafish models recapitulates the cardiac and limb phenotypes of Holt-Oram syndrome (32, 33, 39) . Tbx5a gene depletion could block cell cycle progression and result in reduced cardiac cell number (40, 41) . Interestingly, hyperactivity of Tbx5a also results in atrioventricular canal malformation and heart looping failure (42) . These findings suggest that a tight regulation of Tbx5a activity is required for the proper formation of atrioventricular canal. We herein identified cul4a as a novel positive regulator of tbx5a. Because the cardiac and forelimb phenotypes of cul4a morphants could be rescued by co-injection of tbx5a mRNA, we conclude that cul4a contributes to atrioventricular canal formation by upregulating tbx5a.
The absence or shortening of pectoral fins in cul4a morphants is reminiscent of the limb phenotypes caused by thalidomide (25) . Knockdown of Crbn, which functions as a substrate receptor for CRL4A and is targeted by thalidomide, results in similar phenotypes (25) . The observations we made with cul4a morphants suggest that thalidomide may also cause cardiac defects in zebrafish. It is possible that thalidomide may exert its teratogenic effect on heart and forelimb via disruption of the cul4a -tbx5a pathway. How cul4a upregulates the expression of tbx5a remains to be further investigated. We previously demonstrated that CRL4B complexes can catalyze the monoubiquitinaton of H2AK119 and coordinate with PRC2 to repress various target genes (14) . In contrast, CRL4A was shown to promote the expression of p16 in mammalian cells (34) . Consistent with the reported positive regulation of gene expression by CRL4A, we found that Cul4a directly binds to the promoter of Tbx5a gene and promotes H3K4me3, a histone mark of active transcription, in rat myocardial cells. Development of new tools and agents suitable for study of epigenetic regulation of zebrafish genes may help shed light on the mechanistic link between cul4a and tbx5a.
The important function of cul4a in cardiovascular development in zebrafish as demonstrated here also suggests that efforts should be made to explore whether germline mutations in CUL4A are associated with human congenital heart diseases.
MATERIALS AND METHODS

Zebrafish maintenance and morpholino oligonucleotide injections
Zebrafish (Danio rerio) embryos were obtained by natural spawning of wild-type TU strain. Embryos were raised and maintained at 28.58C in system water. Morpholinos (Gene Tools LLC, OR, USA) were designed to target the splicing site of cul4a (cul4a-MO1:
′ -GCTGGTGCTGAACATCTTCTGCCAT-3 ′ , was designed to target the 5 ′ -UTR of cul4a and thus to block its translation. Morpholino cul4b-MO2:
′ -TCCCTTATCTAGTAATCCTACCATG-3 ′ ) contains five mismatched bases with cul4a-MO1 and cul4b-MO1, respectively. A BLAST search indicated that the morpholinotargeted sequences are unique in the zebrafish genome. All morpholinos were diluted to 0.0625 mM in sterile water. Fertilized zebrafish eggs at the one-to four-cell stage were positioned into agar slots, and injected with 1, 2 or 4 ng of morpholino using glass capillary needles. Human wild-type CUL4A, CUL4B, zebrafish cul4a, cul4b and tbx5a mRNA were in vitro transcribed from linearized pCS2+ constructs using SP6 Message Machine Kit (Ambion). For the rescue experiments, 100 pg mRNA was injected. Primers are: zfcul4a mRNA forward: CGCATCGA TATGGCAGAAGATGTTCAGCAC, reverse: CGCGAATTC GTCCTCCACCTCTTTCCCTC; zfcul4b mRNA forward: CG CGGATCCAGCATTAGTAGATTAGCGATT, reverse: CGG CTCGAGAGCCACATAGTTGTATTGAT; HCUL4A mRNA forward: CGGGATCCATGGCGGACGAGGCCCCGC, reverse: CGCATCGATCAGTACCACTACGTGGCC; HCUL4B mRNA forward: CGGGATCCATGTTTCCAACAGGTTTT, reverse: CGCATCGATCAGTACAACTATATTGCA; tbx5a mRNA forward: CCGGAATTCATGGCGGACAGTGAAGACAC, reverse: CCGTCTAGATGCATGATGCTGACGCTGTG.
Histology and immunohistochemistry
Histological staining (Haematoxylin and eosin, H&E) on paraffin (4 mm) sections was performed as previously described (43) . Whole-mount immunohistochemistry of zebrafish heart was carried out using S46 and MF20 antibodies (Developmental Studies Hybridoma Bank, University of Iowa, IA, USA) as described (44) . Sections of zebrafish heart were dewaxed, rehydrated and stained with antibodies against PCNA (Santa Cruz).
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed with digoxigenin-labeled RNA probes essentially as described (45) . At least 10 embryos were used in each assay. All in situ hybridizations were repeated at least three times. The cardiac myosin light chain 2 (cmlc2) riboprobe was a gift from Dr. David Kimelman (University of Washington), and ventricular myosin heavy chain (vmhc) riboprobe was a gift from Dr Deborah Yelon (New York University School of Medicine). The antisense probes for tbx5a and cul4a were obtained by RT-PCR, the primers are: zfcul4a probe forward: GCGGGGCCCCTCG GGGGGTCTTATTG, reverse: GCCGTCGACTGGCTGTGA TTGAGTGTTG; zftbx5a probe forward: GGGCCCGAGCA CCCGGAGGAAACC, reverse: CGCGAATTCGTCCTCCAC CTCTTTCCCTC.
TUNEL assay and BrdU incorporation
TUNEL staining on paraffin (4 mm) sections of zebrafish embryos was performed using the In Situ Cell Death Detection Kit (Roche). BrdU incorporation assay of pectoral fin was performed as previously described (46) . To analyze cell proliferation in the zebrafish heart, 2 nl of 1 mg/ml BrdU was injected in the pericardiac cavity of tricaine anesthetized embryos, which were fixed 1 h later as previously described (30) . Whole-mount immunohistochemistry or immunofluorescence of zebrafish heart was carried out using BrdU antibody (Caltag Laboratories).
Quantitative real-time PCR
The total RNA was extracted from 32 hpf embryos or H9C2 cells using the Trizol reagent (Invitrogen Technologies, USA) according to the manufacturer's protocol. First-strand cDNA was reverse transcribed using random primer and RevertAID Reverse transcriptase (Fermentas). The cDNA was analyzed immediately or stored at 2208C. Quantitative-PCR was performed by Roche 480 real-time PCR system. The sequence-specific primers were designed using Primer 5 software. The SYBR green (Roche) method was used to quantify cDNA. GAPDH was used as control to confirm similar amount of starting cDNA from all stages tested. The relative expression levels of other genes were computed with respect to the amount of GAPDH in each sample by dividing the amount of other genes. Specificity of each reaction was controlled by melting curve analysis. Primers: zfcul4a forward: TAGCGTTGTTGT TATCGTCATTAT, reverse: TGTCAGCTTGGGTCTGTCT TTA; zftbx5a forward: ACACCTTTCGGCTCCAAAACT, reverse: CTTTGTCCACAGCTCTCGCTC; zfbmp2a forward: CACTCAGGTGTTTTTTGCGG, reverse: CTGGAGCTGGA CGGATCTTC; zfhand2 forward: GCCAAAGAAGAAAGGC GAAA, reverse: GCCTCATTTCGTCTTTTGCT; zffgf10 forward: CTCATCGTCTGCCGTGGTG, reverse: GTCAATGC CGAAATCCCTC; zfbeta-actin forward: CGAGCTGTCTTC CCATCCA, reverse: TCACCAACGTAGCTGTCTTTCTG; rat Cul4a forward: GCTCTCACAAAGTCTCCCCCA, reverse: CCACTTCGTTCACGCCCAAT; rat Cul4b forward: GATTCC TCAGCCATTTTCGTAT, reverse: AGAGATTCGGCGTCC CCTTC; rat Tbx5a forward: AGCACCGAGCACCCCTATAA, reverse: CCGCTGGGCTGACTCTGT; rat Gapdh forward: AAGTTCAACGGCACAGTCAAGG, reverse: CAGCGGAA GGGGCGGAGA.
Western blotting
Embryos were homogenized on ice in lysis buffer. Western blotting was performed as described (4) . The primary antibodies used include anti-b-actin antibody (Sigma), anti-tbx5a antibody (AVIVA), anti-Cul4a antibody (Abcam) and anti-Gapdh antibody (Sigma).
RNA interference
Small interfering RNA (siRNA) duplexes were used to knock down Cul4a in H9C2 cells. The Cul4a and negative control siRNA duplexes were purchased from GenePharma, and the oligonucleotide sequences were as follows: cul4a, 5
′ -GGA GAUAAGUUCAUCUUCATT-3 ′ ; negative control, 5 ′ -UUCU CCGAACGUGUCACGUdTdT-3 ′ .
ChIP assay
ChIPs were performed as described previously (14) . Briefly, cells were mechanically dissociated by pipetting and 1 × 10 7 cells were cross-linked with 1% formaldehyde, sonicated, precleaned and incubated with 5 mg of antibody per reaction. Complexes were washed with low and high salt buffers, and the DNA was extracted and precipitated. The enrichment of the DNA template was analyzed by PCR using primers specific to Tbx5a promoter. The sources of the antibodies were: anti-Cul4a (Abcam) and anti-H3K4me3 (Millipore). Protein A/G Sepharose CL-4B beads were from Amersham Biosciences, and protease inhibitor mixture cocktail was from Roche Applied Science. The primers used were: rat Tbx5a promoter fragment a forward: CCCTAC-CAACCACCTCTG, reverse: GCTGGCTAACTCAAACTGC; fragment b forward: ATCTGGGACTGATTTTAGGC, reverse: CGGAGAATAAAGGATAGTAAT; fragment c forward: GC TGGGAAGAGGAGAAGA, reverse: AAGCCATCGGGTAG AAAC; fragment d forward: TTTCTACCCGATGGCTTCC, reverse: GTTTGACCCTTCACTCCA.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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